Inventor
RONGZE KUANG
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes22%
C07BGeneral methods of organic chemistry6%
C07KPeptides6%
PatentTitleYear
12,528,786Plasma kallikrein inhibitors202612,466,831Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use202512,459,927Plasma kallikrein inhibitors202512,428,397Factor XI activation inhibitors202512,414,952Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use202512,304,899Factor XI activation inhibitors2025Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2025–2026Patents assigned to MERCK SHARP & DOHME LLC (6)· patent assignee history
2025–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME LLC | 6 | 2025–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2025–2026 |